Bristol Myers Squibb (BMY): aksiya narxi va yangiliklar

Belgilar Belgilar	Narxi	Oʻzgartirishlar	Dinamika (%)	Trend	Avvalgi yopilish narxi	Ochish	Yuqori	Past	Hajmi	Bozor kapitali
SIXB Materials SIXB Materials	SIXB -0,21%	1 091,51	-2,30	-0,21%	—	1 093,81	1 096,52	1 100,22	1 091,51	—	—
SIXC Communications SIXC Communications	SIXC +0,22%	610,11	+1,34	+0,22%	—	608,77	608,77	612,97	608,77	—	—
SIXE Energy SIXE Energy	SIXE -1,34%	1 237,98	-16,83	-1,34%	—	1 254,81	1 253,01	1 253,87	1 226,33	—	—
SIXI Industrials SIXI Industrials	SIXI -0,93%	1 744,71	-16,40	-0,93%	—	1 761,11	1 764,27	1 766,88	1 744,71	—	—
SIXM Financials SIXM Financials	SIXM -0,37%	640,18	-2,40	-0,37%	—	642,58	644,87	648,48	640,18	—	—
SIXR Staples SIXR Staples	SIXR -0,18%	849,58	-1,55	-0,18%	—	851,13	855,66	858,75	845,56	—	—
SIXRE Real estate SIXRE Real estate	SIXRE -0,23%	217,48	-0,50	-0,23%	—	217,98	217,98	218,65	216,88	—	—
SIXT Technology SIXT Technology	SIXT +1,52%	3 260,69	+48,86	+1,52%	—	3 211,83	3 227,21	3 268,38	3 226,55	—	—
SIXU Utilities SIXU Utilities	SIXU -0,69%	942,45	-6,53	-0,69%	—	948,98	948,58	957,83	941,97	—	—
SIXV Health care SIXV Health care	SIXV -0,52%	1 466,80	-7,72	-0,52%	—	1 474,52	1 479,03	1 481,04	1 466,80	—	—
SIXY Discretionary SIXY Discretionary	SIXY +0,22%	2 397,50	+5,38	+0,22%	—	2 392,12	2 396,95	2 421,22	2 382,32	—	—

Q1 2026 daromadi • nashr etilgan • Aksiya boʻyicha daromad kutilganidan yuqori +11,14% • Daromad kutilganidan yuqori +5,24%

Natijalarini ochish

BMY:NYSE

Bristol Myers Squibb

58,22 US$

-3,91%

(-2,37) 1K

58,50 US$

+0,48% (+0,28)

Yopilgandan keyin

Savdolar yopilgan: 1-may, 16:00:04 (GMT-4) · USD

Barcha belgilar

YBB

MAKS

	Belgi	Narxi	Oʻzgartirishlar	Dinamika (%)

BMY tikeri uchun statistika yaratilmoqda...

Ochish

60,02 US$

Yuqori

60,08 US$

Past

58,03 US$

Bozor kapitali

118,87 mlrd

Hajmi

18,37 mln

Dividend

4,33%

Choraklik dividendlar

0,63 US$

Eks-dividend sanasi

2-yan, 2026

P/E koeffitsiyenti

16,34

52 haftalik eng yuqori

62,89 US$

52 haftalik eng past

42,52 US$

Aksiya boʻyicha daromad

3,56 US$

Beta

0,27

Muomaladagi aksiyalar

2,04 mlrd

Xodimlar soni

32 ming

Aloqador aksiyalar

Yangiliklar

Internetdagi manbalardan

MarketBeat

40 daqiqa oldin

Bristol Myers Squibb Company $BMY Shares Sold by Danske Bank A S

Seeking Alpha

2 soat oldin

Bristol Myers Squibb: The CAR-T Giant The Market Is Undervaluing (NYSE:BMY)

TradingKey

16 soat oldin

Bristol-Myers Squibb Co Stock (BMY) Moved Down by 3.18% on May 1: Drivers Behind the Movement

Seeking Alpha

1 kun oldin

Bristol-Myers Squibb Company 2026 Q1 - Results - Earnings Call Presentation (NYSE:BMY) 2026-04-30

Profil

Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2024, 71% of the company's revenues came from the United States. The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia

Bristol Myers Squibb haqida

CEOChris Boerner

Xodimlar soni32,5 ming

Asos solingan1887

Bosh ofislarNyu-York shahri, Nyu-York, Amerika Qo‘shma Shtatlari

Sektor-

Veb-saytbms.com

Barcha qiymatlar – USD	mar, 2025	iyn, 2025	sen, 2025	dek, 2025
Daromad	11,20 mlrd	12,27 mlrd	12,22 mlrd	12,50 mlrd
Sotilgan mahsulotning tannarxi	3,02 mlrd	3,36 mlrd	3,31 mlrd	3,51 mlrd
Daromad narxi	3,02 mlrd	3,36 mlrd	3,31 mlrd	3,51 mlrd
Tadqiqot va ishlanmalarga xarajatlar	2,24 mlrd	2,26 mlrd	2,43 mlrd	2,56 mlrd
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar	-	-	-	-
Tijoriy, umumiy va maʼmuriy xarajatlar	1,58 mlrd	1,69 mlrd	1,79 mlrd	2,09 mlrd
Operatsion xarajatlar	4,65 mlrd	4,78 mlrd	5,05 mlrd	5,47 mlrd
Jami operatsion xarajatlar	7,66 mlrd	8,14 mlrd	8,36 mlrd	8,98 mlrd
Operatsion daromad	3,54 mlrd	4,13 mlrd	3,86 mlrd	3,52 mlrd
Boshqa nooperatsion daromad	494,00 mln	399,00 mln	529,00 mln	544,00 mln
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar	2,97 mlrd	1,77 mlrd	3,11 mlrd	1,47 mlrd
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno	3,70 mlrd	4,22 mlrd	4,07 mlrd	3,86 mlrd
Daromad soligʻi boʻyicha xarajat	509,00 mln	460,00 mln	919,00 mln	384,00 mln
Amaldagi soliq stavkasi	17,13%	25,96%	29,51%	26,12%
Boshqa operatsion xarajatlar	-	-	-	-
Sof foyda	2,46 mlrd	1,31 mlrd	2,20 mlrd	1,09 mlrd
Sof foyda marjasi	21,93%	10,68%	18,01%	8,69%
Har bir aksiya foydasi	1,80	1,46	1,63	1,26
Foizlar va investitsiyalardan olingan daromadlar	138,00 mln	139,00 mln	161,00 mln	148,00 mln
Foizlarni toʻlash xarajatlari	-493,00 mln	-485,00 mln	-482,00 mln	-432,00 mln
Foizlarni toʻlash boʻyicha sof xarajatlar	-355,00 mln	-346,00 mln	-321,00 mln	-284,00 mln
Amortizatsiya ajratmalari	-	-	-	-
EBITDA	4,55 mlrd	5,12 mlrd	4,91 mlrd	4,54 mlrd
Aktivlarni sotishdan olingan foyda yoki zarar	-20,00 mln	-7,00 mln	-9,00 mln	-

AI kontentda xatolar boʻlishi mumkin. Batafsil

YordamFikr-mulohazaMaxfiylik Shartlar Majburiyatlardan voz kechish

Finance

Tahlil